GEODE CAPITAL MANAGEMENT, LLC - OPIANT PHARMACEUTICALS INC ownership

OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 41 filers reported holding OPIANT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of OPIANT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$985
-99.8%
48,591
-0.3%
0.00%
Q3 2022$523,000
-10.1%
48,727
+0.3%
0.00%
Q2 2022$582,000
-43.4%
48,560
+1.2%
0.00%
Q1 2022$1,028,000
-39.1%
47,998
-4.5%
0.00%
Q4 2021$1,689,000
+30.6%
50,2440.0%0.00%
Q3 2021$1,293,000
+626.4%
50,244
+290.0%
0.00%
Q2 2021$178,000
+30.9%
12,8820.0%0.00%
Q1 2021$136,00012,8820.00%
Other shareholders
OPIANT PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
HealthInvest Partners AB 210,000$2,518,0005.80%
APIS CAPITAL ADVISORS, LLC 196,000$2,350,0002.65%
Stonepine Capital Management, LLC 152,278$1,826,0000.85%
Parkman Healthcare Partners LLC 75,632$907,0000.33%
PERRITT CAPITAL MANAGEMENT INC 30,500$366,0000.22%
ESSEX INVESTMENT MANAGEMENT CO LLC 50,405$604,0000.10%
ACADIAN ASSET MANAGEMENT LLC 126,978$1,523,0000.01%
Trexquant Investment LP 12,219$147,0000.01%
Renaissance Technologies 193,415$2,319,0000.00%
TWO SIGMA ADVISERS, LP 74,400$892,0000.00%
View complete list of OPIANT PHARMACEUTICALS INC shareholders